BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20367531)

  • 1. Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.
    Viola JR; El-Andaloussi S; Oprea II; Smith CI
    Expert Opin Drug Deliv; 2010 Jun; 7(6):721-35. PubMed ID: 20367531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral vector-mediated gene transfer for CNS disease.
    Snyder BR; Boulis NM; Federici T
    Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models.
    O'Neill MJ; Bourre L; Melgar S; O'Driscoll CM
    Drug Discov Today; 2011 Mar; 16(5-6):203-18. PubMed ID: 21262379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.
    Bondì ML; Craparo EF
    Expert Opin Drug Deliv; 2010 Jan; 7(1):7-18. PubMed ID: 20017658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-mediated gene delivery.
    Yoon CS; Park JH
    Expert Opin Drug Deliv; 2010 Mar; 7(3):321-30. PubMed ID: 20166854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in non-viral vector-mediated gene delivery.
    Pathak A; Patnaik S; Gupta KC
    Biotechnol J; 2009 Nov; 4(11):1559-72. PubMed ID: 19844918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives.
    Neu M; Fischer D; Kissel T
    J Gene Med; 2005 Aug; 7(8):992-1009. PubMed ID: 15920783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant polymer-protein fusion: a promising approach towards efficient and targeted gene delivery.
    Hatefi A; Megeed Z; Ghandehari H
    J Gene Med; 2006 Apr; 8(4):468-76. PubMed ID: 16416505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of plasmid DNA-based non-viral gene medicine.
    Nishikawa M; Takakura Y; Hashida M
    Adv Genet; 2005; 53():47-68. PubMed ID: 16240990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to gene delivery using synthetic vectors.
    Read ML; Logan A; Seymour LW
    Adv Genet; 2005; 53():19-46. PubMed ID: 16240989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-directed muscular dystrophy gene therapy.
    Tang Y; Cummins J; Huard J; Wang B
    Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances with the use of bio-inspired vectors towards creation of artificial viruses.
    McCarthy HO; Wang Y; Mangipudi SS; Hatefi A
    Expert Opin Drug Deliv; 2010 Apr; 7(4):497-512. PubMed ID: 20151849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of plasmid and oligonucleotide nanometric particles.
    Dauty E; Behr JP; Remy JS
    Gene Ther; 2002 Jun; 9(11):743-8. PubMed ID: 12032701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
    de Martimprey H; Vauthier C; Malvy C; Couvreur P
    Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
    Pringle IA; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular routing of plasmid DNA during non-viral gene transfer.
    Lechardeur D; Verkman AS; Lukacs GL
    Adv Drug Deliv Rev; 2005 Apr; 57(5):755-67. PubMed ID: 15757759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies.
    Wang T; Upponi JR; Torchilin VP
    Int J Pharm; 2012 May; 427(1):3-20. PubMed ID: 21798324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled filamentous nanostructures for drug/gene delivery applications.
    Lee JH; Choi YJ; Lim YB
    Expert Opin Drug Deliv; 2010 Mar; 7(3):341-51. PubMed ID: 20201738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosomal disruptors in non-viral gene delivery.
    Minchin RF; Yang S
    Expert Opin Drug Deliv; 2010 Mar; 7(3):331-9. PubMed ID: 20201737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.